Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
Study data from A. Gupta and co-authors update knowledge of tuberculosis
April 1st, 2009
According to recent research published in the journal Infection and Immunity, "As the disease caused by Mycobacterium tuberculosis continues to be a burden, there is a concerted effort to find new vaccines to combat this problem. One of the important vaccine strategies is whole bacterial vaccines." "This approach relies on multiple antigens and built-in adjuvanticity. Other mycobacterial strains which share cross-reactive antigens with M. tuberculosis have been considered as alternatives to M. bovis for vaccine use. One such strain, ''Mycobacterium w'', had been evaluated for its immunomodulatory properties in leprosy. A vaccine against leprosy based on killed M....
Source: Vaccine Weekly (2009-04-01)
|
